Host soluble factors that regulate the synthesis of the major core protein of the bovine leukemia virus (BLV) in a naturally infected neoplastic B-cell line

Veterinary Immunology and Immunopathology

Volumn 131, Issue 3-4, 2009, Pages 246-258

  Gutiérrez, Silvina ^a   Ceriani, Carolina ^a   Juliarena, Marcela ^a   Ferrer, Jorge F ^b  

^a UNIVERSIDAD NACIONAL DEL CENTRO DE LA PROVINCIA DE BUENOS AIRES   (Argentina)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Casein; BLVp24; Bovine leukemia virus (BLV); Milk; NBC 10 cells; Plasma; Retrovirus; Transforming growth factor (TGF ); Whey

Indexed keywords

GAG PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; BOVINE LEUKEMIA VIRUS; CATTLE DISEASE; CONTROLLED STUDY; FETUS; LYMPHOCYTE CULTURE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS REGULATION; THROMBOCYTE; VIRUS NEUTRALIZATION;

ANIMALS; ANTIBODIES, NEUTRALIZING; B-LYMPHOCYTES; BLOOD PLATELETS; CATTLE; CELL LINE, TUMOR; ENZOOTIC BOVINE LEUKOSIS; FEMALE; FETAL BLOOD; HOST-PATHOGEN INTERACTIONS; LEUKEMIA VIRUS, BOVINE; MILK; PREGNANCY; RECOMBINANT PROTEINS; TRANSFORMING GROWTH FACTOR BETA; VIRAL CORE PROTEINS;

BOS; BOVINAE; BOVINE LEUKEMIA VIRUS; DELTARETROVIRUS;

EID: 69949182341     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetimm.2009.04.017     Document Type: Article

References (63)

1. Abbott M.A., Poiesz B.J., Byrne B.C., Kwok S., Sninsky J.J., and Ehrlich G.D. Enzymatic gene amplification: qualitative and quantitative methods for detecting proviral DNA amplified in vitro. J. Infect. Dis. 158 (1988) 1158-1169
2. Andrews A.T. The composition, structure and origin of proteose-peptone component 5 of bovine milk. Eur. J. Biochem. 90 (1978) 59-65
3. Andrews A.T. The composition, structure and origin of proteose-peptone component 8F of bovine milk. Eur. J. Biochem. 90 (1978) 67-81
4. Arnulf B., Villemain A., Nicot C., Mordelet E., Charneau P., Kersual J., Zermati Y., Mauviel A., Bazarbachi A., and Hermine O. Human T-cell lymphotropic virus oncoprotein Tax represses TGF-beta 1 signaling in human T cells via c-Jun activation: a potential mechanism of HTLV-I leukemogenesis. Blood 100 (2002) 4129-4138
5. Baliga, V., Ferrer, J.F., 1977. Expression of the bovine leukemia virus and its internal antigen in blood lymphocytes. Proc. Soc. Exp. Biol. Med. 156, 388-391.
6. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
7. Brown P.D., Wakefield L.M., Levinson A.D., and Sporn M.B. Physicochemical activation of recombinant latent transforming growth factor-beta's 1, 2, and, 3. Growth Factors 3 (1990) 35-43
8. Chatterjee R., Gupta P., Kashmiri S.V., and Ferrer J.F. Phytohemagglutinin activation of the transcription of the bovine leukemia virus genome requires de novo protein synthesis. J. Virol. 54 (1985) 860-863
9. Djilali S., Parodi A.L., and Levy D. Bovine leukemia virus replicates in sheep B lymphocytes under a T cell released factor. Eur. J. Cancer Clin. Oncol. 23 (1987) 81-85
10. Driscoll D.M., Baumgartener L.E., and Olson C. Concanavalin A and the production of bovine leukemia virus antigen in short-term lymphocyte cultures. J. Natl. Cancer Inst. 58 (1977) 1513-1514
11. Eigel W.N., and Keenan T.W. Identification of proteose-peptone component 8-slow as a plasmin derived fragment of bovine β-casein. Int. J. Biochem. 10 (1979) 529-535
12. Ferrer J.F. Bovine lymphosarcoma. Adv. Vet. Sci. Comp. Med. 24 (1980) 1-68
13. Ferrer J.F., Avila L., and Stock N.D. Recent electron microscopic and immunologic studies on bovine cell cultures containing C-type viruses. Bibl. Haematol. 39 (1973) 206-214
14. Ferrer J.F., Marshak R.R., Abt D.A., and Kenyon S.J. Relationship between lymphosarcoma and persistent lymphocytosis in cattle: a review. J. Am. Vet. Med. Assoc. 175 (1979) 705-708
15. Ferrer J.F., Stock N.D., and Lin P. Detection of replicating C-type viruses in continuous cell cultures established from cows with leukemia: effect of the culture medium. J. Natl. Cancer Inst. 47 (1971) 613-621
16. Ghezzi P.C., Dolcini G.L., Gutierrez S.E., Bani P.C., Torres J.O., Arroyo G.H., and Esteban E.N. Bovine leukemia virus (BLV): prevalence in the Cuenca Lechera Mar y Sierras from 1994 to 1995. Rev. Argent. Microbiol. 29 (1997) 137-146
17. Gleizes P.E., Munger J.S., Nunes I., Harpel J.G., Mazzieri R., Noguera I., and Rifkin D.B. TGF-beta latency: biological significance and mechanisms of activation. Stem Cells 15 (1997) 190-197
18. Gupta P., Chatterjee R., and Cai Q. Prevalence of the plasma bovine leukaemia virus blocking factor in cattle from a commercial dairy herd. Vet. Rec. 125 (1989) 5-6
19. Gupta P., and Ferrer J.F. Expression of bovine leukemia virus genome is blocked by a nonimmunoglobulin protein in plasma from infected cattle. Science 215 (1982) 405-407
20. Gupta P., Kashmiri S.V., and Ferrer J.F. Transcriptional control of the bovine leukemia virus genome: role and characterization of a non-immunoglobulin plasma protein from bovine leukemia virus-infected cattle. J. Virol. 50 (1984) 267-270
21. Gutierrez S.E., Dolcini G.L., Arroyo G.H., Rodriguez Dubra C., Ferrer J.F., and Esteban E.N. Development and evaluation of a highly sensitive and specific blocking enzyme-linked immunosorbent assay and polymerase chain reaction assay for diagnosis of bovine leukemia virus infection in cattle. Am. J. Vet. Res. 62 (2001) 1571-1577
22. Hare W.C., Lin P.S., and Zachariasewycz E. Studies on 12 cell lines established from mononuclear leukocytes of cattle with lymphosarcoma. Cancer 22 (1968) 1074-1084
23. Hollsberg P., Ausubel L.J., and Hafler D.A. Human T cell lymphotropic virus type I-induced T cell activation resistance to TGF-beta 1-induced suppression. J. Immunol. 153 (1994) 566-573
24. Holy, L., 1983. Capítulo 13: Gravidez, preñez o gestación. Bases Biológicas de la Reproducción. Editorial Diana, México, p. 210.
25. Jensen W.A., Sheehy S.E., Fox M.H., Davis W.C., and Cockerell G.L. In vitro expression of bovine leukemia virus in isolated B-lymphocytes of cattle and sheep. Vet. Immunol. Immunopathol. 26 (1990) 333-342
26. Jensen W.A., Wicks-Beard B.J., and Cockerell G.L. Inhibition of protein kinase C results in decreased expression of bovine leukemia virus. J. Virol. 66 (1992) 4427-4433
27. Jones K.S., Akel S., Petrow-Sadowski C., Huang Y., Bertolette D.C., and Ruscetti F.W. Induction of human T cell leukemia virus type I receptors on quiescent naive T lymphocytes by TGF-beta. J. Immunol. 174 (2005) 4262-4270
28. Kehrl J.H., Wakefield L.M., Roberts A.B., Jakowlew S., Alvarez-Mon M., Derynck R., Sporn M.B., and Fauci A.S. Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth. J. Exp. Med. 163 (1986) 1037-1050
29. Kettmann R., Deschamps J., Cleuter Y., Couez D., Burny A., and Marbaix G. Leukemogenesis by bovine leukemia virus: proviral DNA integration and lack of RNA expression of viral long terminal repeat and 3′ proximate cellular sequences. Proc. Natl. Acad. Sci. U.S.A. 79 (1982) 2465-2469
30. Kettmann R., Marbaix G., Cleuter Y., Portetelle D., Mammerickx M., and Burny A. Genomic integration of bovine leukemia provirus and lack of viral RNA expression in the target cells of cattle with different responses to BLV infection. Leuk. Res. 4 (1980) 509-519
31. Kidd L.C., and Radke K. Lymphocyte activators elicit bovine leukemia virus expression differently as asymptomatic infection progresses. Virology 217 (1996) 167-177
32. Kim S.J., Kehrl J.H., Burton J., Tendler C.L., Jeang K.T., Danielpour D., Thevenin C., Kim K.Y., Sporn M.B., and Roberts A.B. Transactivation of the transforming growth factor beta 1 (TGF-beta 1) gene by human T lymphotropic virus type 1 tax: a potential mechanism for the increased production of TGF-beta 1 in adult T cell leukemia. J. Exp. Med. 172 (1990) 121-129
33. Lagarias D.M., and Radke K. Transcriptional activation of bovine leukemia virus in blood cells from experimentally infected, asymptomatic sheep with latent infections. J. Virol. 63 (1989) 2099-2107
34. Letterio J.J., and Roberts A.B. Regulation of immune responses by TGF-beta. Annu. Rev. Immunol. 16 (1998) 137-161
35. Lucas C., Bald L.N., Fendly B.M., Mora-Worms M., Figari I.S., Patzer E.J., and Palladino M.A. The autocrine production of transforming growth factor-beta 1 during lymphocyte activation. A study with a monoclonal antibody-based ELISA. J. Immunol. 145 (1990) 1415-1422
36. Marshak R.R., Hare W.C., Abt D.A., Croshaw Jr. J.E., Switzer J.W., Ipsen I., Dutcher R.M., and Martin J.E. Occurrence of lymphocytosis in dairy cattle herds with high incidence of lymphosarcoma. Ann. NY Acad. Sci. 108 (1963) 1284-1301
37. McDonald H.C., and Ferrer J.F. Detection, quantitation and characterization of the major internal virion antigen of the bovine leukemia virus by radioimmunoassay. J. Natl. Cancer Inst. 57 (1976) 875-882
38. McGahon A., Martin S., Bissonnette R., Mahboubi A., Shi Y., Mogil R., Nishioka W., and Green D. The end of the (cell) line: methods for the study of apoptosis in vitro. Meth. Cell Biol. 46 (1995) 153-185
39. Meirom R., Moss S., Brenner J., Heller D., and Trainin Z. Levels and role of cytokines in bovine leukemia virus (BLV) infection. Leukemia 11 3 (1997) 219-220
40. Miller J.M., Miller L.D., Olson C., and Gillette K.G. Virus-like particles in phytohemagglutinin-stimulated lymphocyte cultures with reference to bovine lymphosarcoma. J. Natl. Cancer Inst. 43 (1969) 1297-1305
41. Mori N., Morishita M., Tsukazaki T., Giam C.Z., Kumatori A., Tanaka Y., and Yamamoto N. Human T-cell leukemia virus type I oncoprotein Tax represses Smad-dependent transforming growth factor beta signaling through interaction with CREB-binding protein/p300. Blood 97 (2001) 2137-2144
42. Moriuchi M., and Moriuchi H. Transforming growth factor-beta enhances human T-cell leukemia virus type I infection. J. Med. Virol. 67 (2002) 427-430
43. Moulin V., Auger F.A., O'Connor-McCourt M., and Germain L. Fetal and postnatal sera differentially modulate human dermal fibroblast phenotypic and functional features in vitro. J. Cell Physiol. 171 (1997) 1-10
44. Munson L., Wilhite A., Boltz V.F., and Wilkinson J.E. Transforming growth factor beta in bovine placentas. Biol. Reprod. 55 (1996) 748-755
45. Murphy-Ullrich J.E., and Poczatek M. Activation of latent TGF-beta by thrombospondin-1: mechanisms and physiology. Cytokine Growth Factor Rev. 11 (2000) 59-69
46. NAHMS, 1996. National Animal Health Monitoring System: high prevalence of BLV in US dairy herds, Available at: http://www.aphis.usda.gov/vs/ceah/cahm/Dairy_Cattle/d96blv.htm.
47. Niermann G.L., and Buehring G.C. Hormone regulation of bovine leukemia virus via the long terminal repeat. Virology 239 (1997) 249-258
48. Niitsu Y., Urushizaki Y., Koshida Y., Terui K., Mahara K., Kohgo Y., and Urushizaki I. Expression of TGF-beta gene in adult T cell leukemia. Blood 71 (1988) 263-266
49. Pyeon D., Diaz F.J., and Splitter G.A. Prostaglandin E(2) increases bovine leukemia virus tax and pol mRNA levels via cyclooxygenase 2: regulation by interleukin-2, interleukin-10, and bovine leukemia virus. J. Virol. 74 (2000) 5740-5745
50. Pyeon D., and Splitter G.A. Regulation of bovine leukemia virus tax and pol mRNA levels by interleukin-2 and -10. J. Virol. 73 (1999) 8427-8434
51. Rogers M.L., Goddard C., Regester G.O., Ballard F.J., and Belford D.A. Transforming growth factor beta in bovine milk: concentration, stability and molecular mass forms. J. Endocrinol. 151 (1996) 77-86
52. Sing G.K., Ruscetti F.W., Beckwith M., Keller J.R., Ellingsworth L., Urba W.J., and Longo D.L. Growth inhibition of a human lymphoma cell line: induction of a transforming growth factor-beta-mediated autocrine negative loop by phorbol myristate acetate. Cell Growth Differ. 1 (1990) 549-557
53. Stock N.D., and Ferrer J.F. Replicating C-type virus in phytohemagglutinin-treated buffy-coat cultures of bovine origin. J. Natl. Cancer Inst. 48 (1972) 985-996
54. Swaisgood, H., 1995. Chapter 5: Nitrogenous components of milk. F. Protein and amino acid composition of bovine milk. Handbook of Milk Composition, pp. 464-472.
55. Taylor J.A., and Jacobs R.M. Effects of plasma and serum on the in vitro expression of bovine leukemia virus. Lab. Invest. 69 (1993) 340-346
56. Trono K.G., Perez-Filgueira D.M., Duffy S., Borca M.V., and Carrillo C. Seroprevalence of bovine leukemia virus in dairy cattle in Argentina: comparison of sensitivity and specificity of different detection methods. Vet. Microbiol. 83 (2001) 235-248
57. Trueblood E.S., Brown W.C., Palmer G.H., Davis W.C., Stone D.M., and McElwain T.F. B-lymphocyte proliferation during bovine leukemia virus-induced persistent lymphocytosis is enhanced by T-lymphocyte-derived interleukin-2. J. Virol. 72 (1998) 3169-3177
58. Tsukiyama K., Onuma M., and Izawa H. Effect of platelet-derived factor on expression of bovine leukemia virus genome. Arch. Virol. 96 (1987) 89-96
59. Van den Broeke A., Cleuter Y., Chen G., Portetelle D., Mammerickx M., Zagury D., Fouchard M., Coulombel L., Kettmann R., and Burny A. Even transcriptionally competent proviruses are silent in bovine leukemia virus-induced sheep tumor cells. Proc. Natl. Acad. Sci. U.S.A. 85 (1988) 9263-9267
60. van den Heuvel M.J., Jefferson B.J., and Jacobs R.M. Isolation of a bovine plasma fibronectin-containing complex which inhibits the expression of bovine leukemia virus p24. J. Virol. 79 (2005) 8164-8170
61. Verma, S., 2007. Development of immunoglobulin diversity at the heavy chain locus of cattle. PhD thesis. University of Glasgow.
62. Zandomeni R.O., Carrera-Zandomeni M., Esteban E., Donawick W., and Ferrer J.F. Induction and inhibition of bovine leukaemia virus expression in naturally infected cells. J. Gen. Virol. 73 Pt 8 (1992) 1915-1924
63. Zandomeni R.O., Esteban E., Carrera-Zandomeni M., and Ferrer J.F. Host soluble factors with blocking and stimulating activity on the expression of the bovine leukemia virus. J. Infect. Dis. 170 (1994) 787-794